Typhoid Vaccines: WHO Position Paper – March 2018
This article, published in the Weekly Epidemiological Record, provides the World Health Organization’s (WHO's) recommendation for the use of typhoid vaccines. Given the advantages of typhoid conjugate vaccine (TCV)—improved immunological properties, suitability for use in younger children, and expected longer duration of protection—over the other available typhoid vaccines, WHO preferentially recommends the prequalified TCV for routine immunization as a single dose for children over six months of age in endemic countries. They also recommend catch-up campaigns for children up to 15 years of age, when feasible. This vaccine can also be used in response to a confirmed outbreak and for travelers. This recommendation replaces WHO’s previous recommendation from 2008.
Author: World Health Organization
» Download file (English, French)
495 KB PDF (Located at apps.who.int)
Also known as: Vaccins antityphoïdiques: note de synthèse de l’OMS – mars 2018
Resource types: Newsletter/article